earnings
XE
NASDAQ · XENE
Xenon Pharmaceuticals Inc.
Healthcare · Biotechnology
$56.76
Up+$0.48 (+0.85%)
Updated Sep 17, 2026, 12:35 PM
SID Score
5.6/10
Composite research score
Smart Money
58/100
Neutral
- Market cap
- 3.37B
- P/E ratio
- -12.39
- Dividend yield
- 0.00%
- 52-week range
- $35.66 – $72.66
- Volume
- 723.67K
- Avg. volume
- 790.48K
Price performance
XENE price history
1M range · 20 trading sessions · Daily adjusted prices
XENE closed at $56.76 after 20 trading sessions, down 8.92% for the selected period.
- Last close
- $56.76
- Period change
- -8.92%
- Period low
- $56.28
- Period high
- $63.79
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 16, 2026 | $56.67 | $57.875 | $56.40 | $56.76 | 723.67K |
| Sep 15, 2026 | $58.13 | $58.13 | $56.17 | $56.28 | 587.02K |
| Sep 14, 2026 | $59.36 | $59.60 | $58.00 | $58.19 | 408.95K |
| Sep 11, 2026 | $60.00 | $60.00 | $58.53 | $58.65 | 466.75K |
| Sep 10, 2026 | $58.74 | $59.395 | $58.00 | $58.80 | 798.78K |
| Sep 9, 2026 | $59.04 | $59.81 | $58.53 | $58.98 | 489.45K |
| Sep 8, 2026 | $58.95 | $60.36 | $58.27 | $59.55 | 608.51K |
| Sep 4, 2026 | $60.02 | $60.57 | $59.43 | $59.75 | 459.23K |
| Sep 3, 2026 | $60.19 | $60.69 | $59.61 | $60.40 | 471.7K |
| Sep 2, 2026 | $60.56 | $61.75 | $59.68 | $60.16 | 637.2K |
| Sep 1, 2026 | $60.48 | $61.155 | $59.54 | $60.00 | 418.79K |
| Aug 31, 2026 | $59.84 | $60.81 | $59.22 | $60.22 | 752.7K |
| Aug 28, 2026 | $61.31 | $61.62 | $59.81 | $59.99 | 587.93K |
| Aug 27, 2026 | $63.13 | $63.775 | $61.85 | $61.93 | 586.97K |
| Aug 26, 2026 | $60.42 | $64.81 | $59.26 | $63.79 | 1.3M |
| Aug 25, 2026 | $61.01 | $61.67 | $60.26 | $60.42 | 418.01K |
| Aug 24, 2026 | $60.77 | $61.045 | $60.00 | $60.56 | 628.83K |
| Aug 21, 2026 | $60.45 | $61.57 | $59.7257 | $60.77 | 792.93K |
| Aug 20, 2026 | $61.41 | $62.51 | $59.27 | $59.73 | 627.24K |
| Aug 19, 2026 | $64.71 | $64.93 | $62.18 | $62.32 | 558.96K |
Latest XENE news
The latest Smart Investors Daily articles mentioning XENE.
Stock researchResearch & News · Analysis
Loading stock research…